Online citations, reference lists, and bibliographies.
← Back to Search

The Occurrence Of Selected Human Pharmaceutical Compounds In UK Estuaries.

K. Thomas, M. Hilton
Published 2004 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
This report describes a scoping study conducted in order to establish whether pharmaceutical compounds may be present in UK estuaries. Surface water samples collected from five UK estuaries were analysed for the presence of 14 pharmaceutical compounds selected from the priority lists of the UK Environment Agency and the Oslo and Paris Commission (OSPAR). The pharmaceutical compounds/metabolites clofibric acid, clotrimazole, dextropropoxyphene, diclofenac, ibuprofen, mefenamic acid, propranolol, tamoxifen and trimethoprim were detected at measurable concentrations in the samples collected. The concentrations of erythromycin, lofepramine, paracetamol, sulfamethoxazole and acetyl-sulfamethoxazole were all below the limits of detection of the methods used (between 4 and 20 ng l(-1)). The anti-fungal agent clotrimazole was the most frequently detected at a maximal concentration of 22 ng l(-1) and a median concentration of 7 ng l(-1). The analgesic compound ibuprofen was detected at a maximal concentration of approximately 930 ng l(-1) and a median concentration of 48 ng l(-1), whilst the other pharmaceutical compounds were detected between the limits of detection of the method used and 570 ng l(-1).
This paper references
The fate of pharmaceutical chemicals in the aquatic environment
M. L. Richardson (1985)
Binding of xenobiotics to the estrogen receptor of spotted seatrout: A screening assay for potential estrogenic effects
P. Thomas (1993)
Contaminants in seawater around England and Wales: results from monitoring surveys, 1990-1992
R. Law (1994)
Vorkommen von Clofibrinsäure in aquatischen System: Führt die therapeutische Anwendung zu einer Belastung von Oberflächen-, Grund- und Trinkwasser?
H. Stan (1994)
Nachweis von Betablockern und Bronchospasmolytika in der aquatischen Umwelt
R. Hirsch (1996)
Effect of the fungicide clotrimazole on the bioconcentration of benzo[a]pyrene in gizzard shad (Dorosoma cepedianum): In vivo and in vitro inhibition of cytochrome P4501A activity
S. Levine (1997)
Pharmaceuticals in the aquatic environment
H. Stan (1997)
Occurrence of the Pharmaceutical Drug Clofibric Acid and the Herbicide Mecoprop in Various Swiss Lakes and in the North Sea
H. Buser (1998)
Occurrence and Distribution of Organic Contaminants in the Aquatic System in Berlin. Part I: Drug Residues and other Polar Contaminants in Berlin Surface and Groundwater
T. Heberer (1998)
Determination of antibiotics in different water compartments via liquid chromatography-electrospray tandem mass spectrometry.
R. Hirsch (1998)
Occurrence and Fate of the Pharmaceutical Drug Diclofenac in Surface Waters: Rapid Photodegradation in a Lake
H. Buser (1998)
Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus
T. Ternes (1998)
Occurrence, fate and effects of pharmaceutical substances in the environment--a review.
B. Halling-Sørensen (1998)
Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil.
M. Stumpf (1999)
Pharmaceuticals and personal care products in the environment: agents of subtle change?
C. Daughton (1999)
Occurrence and Environmental Behavior of the Chiral Pharmaceutical Drug Ibuprofen in Surface Waters and in Wastewater
H. Buser (1999)
Occurrence of antibiotics in the aquatic environment.
R. Hirsch (1999)
Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin.
Halling-Sørensen (2000)
Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/l level in surface and waste water.
S. Ollers (2001)
Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri.
M. Farré (2001)
Pharmaceuticals in the Environment
K. Kümmerer (2001)
Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry.
W. Ahrer (2001)
Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea.
S. Weigel (2002)
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
O. Jones (2002)
Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance.
D. Kolpin (2002)
Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects.
M. Cleuvers (2003)
Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry.
M. Hilton (2003)
Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac.
B. Ferrari (2003)
Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris.
D. Pascoe (2003)

This paper is referenced by
A comprehensive review on environmental toxicity of azole compounds to fish.
J. Bhagat (2021)
Environmental risk assessment and bioaccumulation of pharmaceuticals in a large urbanized estuary.
V. Fonseca (2021)
Accelerated solvent extraction-gel permeation chromatography-gas chromatography-tandem mass spectrometry to rapid detection of clotrimazole residue in animal-derived food
Chao Han (2021)
Recent developments in physical, biological, chemical, and hybrid treatment techniques for removing emerging contaminants from wastewater.
S. Ahmed (2021)
Global trends of antibiotics research: comparison using network analysis to map the tendencies of antibiotics in water, soil and sediment
Chunli Zheng (2021)
Sources and occurrence of pharmaceutical residues in offshore seawater
Nikiforos A. Alygizakis (2021)
Rapid direct analysis of river water and machine learning assisted suspect screening of emerging contaminants in passive sampler extracts.
Alexandra K Richardson (2021)
Antibiotic residues in the aquatic environment – current perspective and risk considerations
C. Monahan (2021)
Origin, fate, and risk assessment of emerging contaminants in groundwater bodies: a holistic review
A Review on the Occurrence and Effect of Pharmaceuticals and Personal Care Products on the Environment
Abirami Balakrishnan (2021)
Potentials and performance of biological processes for treatment of pharmaceuticals and personal care products in wastewater
M. N. Taher (2021)
Abundance, fate, and effects of pharmaceuticals and personal care products in aquatic environments.
A. Adeleye (2021)
A multi-residue chiral liquid chromatography coupled with tandem mass spectrometry method for analysis of antifungal agents and their metabolites in aqueous environmental matrices.
R. Wattanayon (2021)
Occurrence and distribution of pharmaceuticals in surface water and sediment of Buffalo and Sundays River estuaries, South Africa and their ecological risk assessment
Assessment of emerging polar organic pollutants linked to contaminant pathways within an urban estuary using non-targeted analysis.
K. Overdahl (2021)
Pharmaceutical residues: New emerging contaminants and their mitigation by nano-photocatalysis
A. Shah (2021)
Spatial and seasonal variations of endocrine disrupting compounds in water and sediment samples of Markman Canal and Swartkops River Estuary, South Africa and their ecological risk assessment.
Occurrence, spatiotemporal distribution and environmental fate of pharmaceutical residues in urban estuaries
Juan Carlos Durán-Álvarez (2021)
Wastewater treatment from pharmaceuticals: a review
O. Shmychkova (2021)
Using the Tea Bag Index to determine how two human pharmaceuticals affect litter decomposition by aquatic microorganisms
W. Hunter (2021)
Fate and Effects of Anticancer Drugs in the Environment
T. Kosjek (2020)
Identifying targets of potential concern by a screening level ecological risk assessment of human use pharmaceuticals in China.
Q. Bu (2020)
Potential of an estuarine salt marsh plant (Phragmites australis (Cav.) Trin. Ex Steud10751) for phytoremediation of bezafibrate and paroxetine
Sofia Dias (2020)
Occurrence, spatiotemporal variation, and ecological risk of antibiotics in the water of the semi-enclosed urbanized Jiaozhou Bay in eastern China.
Shuang Lu (2020)
A margin of safety approach for the assessment of environmentally realistic chemical mixtures in the marine environment based on combined passive sampling and ecotoxicity testing.
Samuel Moeris (2020)
Pharmaceuticals as emerging micropollutants in aquatic environments
Afsane Chavoshani (2020)
Occurrence of Cytostatics in Different Water Compartments
P. Verlicchi (2020)
Effects of Propranolol on Growth, Lipids and Energy Metabolism and Oxidative Stress Response of Phaeodactylum tricornutum
B. Duarte (2020)
Can salicylic acid modulate biochemical, physiological and population alterations in a macrophyte species under chemical stress by diclofenac?
G. D. Alkimin (2020)
Contaminants of emerging concern in the Basque coast (N Spain): Occurrence and risk assessment for a better monitoring and management decisions.
O. Solaun (2020)
Occurrence, interactive effects and ecological risk of diclofenac in environmental compartments and biota - a review.
P. Sathishkumar (2020)
Submerged photocatalytic membrane reactor with suspended and immobilized N-doped TiO2 under visible irradiation for diclofenac removal from wastewater
Van-Huy Nguyen (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar